An Advancing Australia
February 2008
An Advancing Australia
Interview with Anna Lavelle
An Advancing Australia
In this exclusive interview, Fintan Walton talks to Anna Lavelle, CEO of AusBiotech, about how the organisation performs its role as the interface between commerce, research scientists and the federal and state government agencies in Australia. Anna also outlines the progress the Australian biotechnology industry has made and discusses how AusBiotech plans to maintain that trend. The emergence of Australia as a significant player in the industry was reflected in the success of AusBiotech 2007 and Anna goes on to talk about the plans to further improve next year’s conference.
About Anna Lavelle
Dr Anna Lavelle was appointed inaugural CEO and Executive Director of AusBiotech in June 2005. She is also a member of the Pharmaceutical Industry Council. Previously Dr Lavelle joined the Australian Red Cross Blood Service (ARCBS) in 1998 as Director responsible for Strategic Planning and Business Development. In 2002, Dr Lavelle was appointed Director of Intellectual Capital, in which role she was responsible for management of the national research and development programme. Before joining ARCBS, Dr Lavelle had commenced employment as an academic at Monash University, Melbourne, after having gained her PhD in Genetics from the University of Melbourne.
About AusBiotech
AusBiotech is Australia's Biotechnology Industry Organisation, which represents over 2550 members and covers the human health, agricultural, medical device, bioinformatics, environmental and industrial sectors in biotechnology.
The organisation is dedicated to the development, growth and prosperity of the Australian biotechnology industry by providing initiatives to drive sustainability and growth, outreach and access to markets, and representation and support for members nationally and around the world.
